Vibecotamab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Vibecotamab Usage And Synthesis

Uses

Vibecotamab (XmAb14045) is a potent bispecific antibody against CD123 and CD3 that stimulates T cell-mediated targeted killing of CD123-expressing cells. Vibecotamab has antitumor activity and can be used in acute myeloid leukaemia studies[1].

References

[1] FarhadRavandiMBBS, et al. Complete Responses in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients on a Weekly Dosing Schedule of Vibecotamab (XmAb14045), a CD123 x CD3 T Cell-Engaging Bispecific Antibody; Initial Results of a Phase 1 Study. Blood, Volume 136, Supplement 1, 5 November 2020, Pages 4-5

Vibecotamab(2138442-13-2)Related Product Information

• Larcaviximab
• Ginisortamab
• Teropavimab
• Keliximab
• Simridarlimab
• Letolizumab
• Ascrinvacumab
• Retifanlimab
• Tuvonralimab
• Tavolimab